Pharmacological profile of the substituted beta-lactam L-659,286: a member of a new class of human PMN elastase inhibitors

Autor: Karen M. Hand, L. Schaeffer, Donald G. Osinga, Alan L. Maycock, Paul E. Finke, Richard A. Mumford, P. Davies, Pam S. Dellea, David Fletcher, C. P. Dorn, R. J. Bonney, T. Nolan, D. Frankenfield, Shrenik S. Shah, William K. Hagmann, Bonnie M. Ashe, James B. Doherty
Rok vydání: 1989
Předmět:
Zdroj: Journal of cellular biochemistry. 39(1)
ISSN: 0730-2312
Popis: Human polymorphonuclear leukocyte elastase (PMN elastase) is inhibited by L-659,286 (7 alpha-methoxy-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4- triaz-in-3-yl)thio]methyl]-5-thia-1-aza-6R-bicyclo[4.2.O]oct-2-ene -2- pyrrolidine carboxamide-5,-dioxide) with a Ki of 0.4 microM. This inhibition is time-dependent, rapid, and only slowly reversible, with a t1/2 of greater than 3 days at 25 degrees C. L-659,286 is also highly selective for PMN elastase, as it does not inhibit thrombin, trypsin, papain, plasmin, chymotrypsin, or cathepsin G. L-659,286 administered intratracheally inhibits lung damage caused by administration via the same route of human PMN elastase into hamsters. In marmosets, L-659,286 is cleared from blood very rapidly after an intravenous injection but is recovered in bronchoalveolar lavage fluid for several hours after intratracheal administration.
Databáze: OpenAIRE